Literature DB >> 8513813

Evaluation of four commercial systems for identification of medically important yeasts.

I Schuffenecker1, A Freydière, H de Montclos, Y Gille.   

Abstract

Four commercially available systems for identification of yeasts were evaluated using 178 clinical isolates and seven reference strains previously identified by a conventional method. After 72 h of incubation, the rate of correct identification was 86.5% with API20C Aux, 86% with Auxacolor, 68% with Mycotube and 51.1% with Candifast. When considering only the reference strains included in the manufacturers' databases, the identification rate was 90%, 91%, 87% and 61.2% respectively. Although the results at 72 h obtained with API20C Aux and Auxacolor were similar, Auxacolor led to more rapid identification of the strains, 67.9% versus 14.6% being identified at 24 h and 80.9% versus 64% being identified at 48 h.

Entities:  

Mesh:

Year:  1993        PMID: 8513813     DOI: 10.1007/BF01967255

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  16 in total

1.  Candida species: emerging hospital bloodstream pathogens.

Authors:  R P Wenzel; M A Pfaller
Journal:  Infect Control Hosp Epidemiol       Date:  1991-09       Impact factor: 3.254

2.  Evaluation of the modified API 20C system for identification of clinically important yeasts.

Authors:  W J Buesching; K Kurek; G D Roberts
Journal:  J Clin Microbiol       Date:  1979-05       Impact factor: 5.948

Review 3.  Candida lusitaniae: an emerging human pathogen.

Authors:  J C Christenson; A Guruswamy; G Mukwaya; P J Rettig
Journal:  Pediatr Infect Dis J       Date:  1987-08       Impact factor: 2.129

4.  Development of resistance to amphotericin B in Candida lusitaniae infecting a human.

Authors:  D Pappagianis; M S Collins; R Hector; J Remington
Journal:  Antimicrob Agents Chemother       Date:  1979-08       Impact factor: 5.191

5.  Disseminated infection with Trichosporon beigelii.

Authors:  D M Walling; D J McGraw; W G Merz; J E Karp; G M Hutchins
Journal:  Rev Infect Dis       Date:  1987 Sep-Oct

6.  Evaluation of the new API 20C strip for yeast identification against a conventional method.

Authors:  G A Land; B A Harrison; K L Hulme; B H Cooper; J C Byrd
Journal:  J Clin Microbiol       Date:  1979-09       Impact factor: 5.948

Review 7.  Emerging fungal pathogens.

Authors:  E J Anaissie; G P Bodey; M G Rinaldi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-04       Impact factor: 3.267

8.  Comparative evaluation of the Iatron serological Candida check kit and the API 20C kit for identification of medically important Candida species.

Authors:  T Shinoda; L Kaufman; A A Padhye
Journal:  J Clin Microbiol       Date:  1981-03       Impact factor: 5.948

Review 9.  Emergence of a new opportunistic pathogen, Candida lusitaniae.

Authors:  R J Blinkhorn; D Adelstein; P J Spagnuolo
Journal:  J Clin Microbiol       Date:  1989-02       Impact factor: 5.948

10.  Evaluation of four commercial biochemical test systems for identification of yeasts.

Authors:  T Bergan; A B Hollum; M Vangdal
Journal:  Eur J Clin Microbiol       Date:  1982-08       Impact factor: 3.267

View more
  13 in total

1.  Comparative evaluation of three commercial identification systems using common and rare bloodstream yeast isolates.

Authors:  Joseph Meletiadis; Michael Arabatzis; Maria Bompola; Konstantinos Tsiveriotis; Stavroula Hini; Efthymia Petinaki; Aristea Velegraki; Loukia Zerva
Journal:  J Clin Microbiol       Date:  2011-05-04       Impact factor: 5.948

2.  Comparison of the new API Candida system to the ID 32C system for identification of clinically important yeast species.

Authors:  H Fricker-Hidalgo; O Vandapel; M A Duchesne; M A Mazoyer; D Monget; B Lardy; B Lebeau; J Freney; P Ambroise-Thomas; R Grillot
Journal:  J Clin Microbiol       Date:  1996-07       Impact factor: 5.948

3.  Ability of RapID Yeast Plus System to identify 304 clinically significant yeasts within 5 hours.

Authors:  T T Kitch; M R Jacobs; M R McGinnis; P C Appelbaum
Journal:  J Clin Microbiol       Date:  1996-05       Impact factor: 5.948

Review 4.  Are the Conventional Commercial Yeast Identification Methods Still Helpful in the Era of New Clinical Microbiology Diagnostics? A Meta-Analysis of Their Accuracy.

Authors:  Brunella Posteraro; Ljupcho Efremov; Emanuele Leoncini; Rosarita Amore; Patrizia Posteraro; Walter Ricciardi; Maurizio Sanguinetti
Journal:  J Clin Microbiol       Date:  2015-05-20       Impact factor: 5.948

Review 5.  Biology of the pathogenic yeast Candida glabrata.

Authors:  A Bialková; J Subík
Journal:  Folia Microbiol (Praha)       Date:  2006       Impact factor: 2.099

6.  Direct identification and recognition of yeast species from clinical material by using albicans ID and CHROMagar Candida plates.

Authors:  C Baumgartner; A M Freydiere; Y Gille
Journal:  J Clin Microbiol       Date:  1996-02       Impact factor: 5.948

7.  Evaluation of latex reagents for rapid identification of Candida albicans and C. krusei colonies.

Authors:  A M Freydiere; L Buchaille; R Guinet; Y Gille
Journal:  J Clin Microbiol       Date:  1997-04       Impact factor: 5.948

8.  Comparison of three commercial systems for identification of yeasts commonly isolated in the clinical microbiology laboratory.

Authors:  J K Wadlin; G Hanko; R Stewart; J Pape; I Nachamkin
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

9.  Evaluation of six commercial systems for identification of medically important yeasts.

Authors:  L Buchaille; A M Freydière; R Guinet; Y Gille
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-07       Impact factor: 3.267

10.  Rapid identification of Candida albicans by using Albicans ID and fluoroplate agar plates.

Authors:  P Rousselle; A M Freydiere; P J Couillerot; H de Montclos; Y Gille
Journal:  J Clin Microbiol       Date:  1994-12       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.